Luiz H. Araujo

PDL1 Regulation by p53 via miR-34

María Angélica Cortez, Cristina Ivan, David R. Valdecanas et al. · JNCI Journal of the National Cancer Institute · 2015 · 657 citations · Full text

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study

Melissa L. Johnson, Byoung Chul Cho, Alexander Luft et al. · Journal of Clinical Oncology · 2022 · 406 citations · Full text

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang et al. · Nature Communications · 2019 · 351 citations · Full text

The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer

John Edwards, Kari Chansky, Paul Van Schil et al. · Journal of Thoracic Oncology · 2019 · 150 citations · Full text

Cancer Detection, Medicine, Multiple Pulmonary Nodule +10

Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma

Marcin Imieliński, Heidi Greulich, Bethany Kaplan et al. · Journal of Clinical Investigation · 2014 · 115 citations

Oncology, Somatic Variant, Oncogenic Agent +14